Breast cancer survival is affected by classic prognostic factors including tumor size, tumor grade, axillary lymph node involvement, disease stage, estrogen receptor (ER) status, and human epidermal growth factor receptor 2 (HER2) overexpression (Galea et al., 1992; Goldhirsch et al., 2005). The gene discussed is ESR1; the disease is neoplasm.